Drug repositioning is an alternative for the treatment of coronavirus COVID-19

dc.creator	Serafin, Marissa B.
dc.creator	Bottega, Angelita
dc.creator	Foletto, Vitória S.
dc.creator	Rosa, Taciéli F. da
dc.creator	Hörner, Andreas
dc.creator	Hörner, Rosmari
dc.date.accessioned	2020-06-23T15:50:59Z
dc.date.available	2020-06-23T15:50:59Z
dc.date.issued	2020-06
dc.description.abstract	Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease.	pt_BR
dc.identifier.citation	SERAFIN, M. B. et al. Drug repositioning is an alternative for the treatment of coronavirus COVID-19. International Journal of Antimicrobial Agents, [S.l.], v. 55, n. 6, June 2020.	pt_BR
dc.identifier.uri	https://repositorio.ufla.br/handle/1/41546
dc.identifier.uri	https://www.sciencedirect.com/science/article/pii/S0924857920301266	pt_BR
dc.language	en_US	pt_BR
dc.publisher	Elsevier	pt_BR
dc.rights	openAccess	pt_BR
dc.source	International Journal of Antimicrobial Agents	pt_BR
dc.subject	COVID-19	pt_BR
dc.subject	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)	pt_BR
dc.title	Drug repositioning is an alternative for the treatment of coronavirus COVID-19	pt_BR
dc.type	Artigo	pt_BR

Arquivos

Agora exibindo 1 - 1 de 1